Emoticare: Serious Game for the Adaptation to the Disease of Adolescents With Type 1 Diabetes Mellitus.
Launched by UNIVERSITY OF VALENCIA · Mar 19, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Diabetes mellitus type 1 (6 months from diagnosis)
- • Informed consent by parents/guardians and participants
- Exclusion Criteria:
- • Diagnosis other than type 1 diabetes mellitus
- • No access to internet or new technologies
- • Not speaking Spanish
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Trial Officials
Marián Pérez-Marín, PhD
Principal Investigator
University of Valencia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported